Trade Summary

2 days ago, Chadwick Jeremy G, serving as Chief Operating Officer at Kymera Therapeutics, Inc. (KYMR), sold 17,184 shares at $79.92 per share, for a total transaction value of $1,373,289.53. Following this transaction, Chadwick Jeremy G now holds 44,018 shares of KYMR.

This sale represents a 28.08% decrease in Chadwick Jeremy G's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 5:50 PM ET, 1 day after the trade was made.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.